Noevir Holdings Co Ltd
TSE:4928
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/S
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Valuation Scenarios
If EV/S returns to its 3-Year Average (2.4), the stock would be worth ¥5 237.49 (19% upside from current price).
| Scenario | EV/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 2 | ¥4 415 |
0%
|
| 3-Year Average | 2.4 | ¥5 237.49 |
+19%
|
| 5-Year Average | 2.5 | ¥5 524.79 |
+25%
|
| Industry Average | 0.9 | ¥1 862.64 |
-58%
|
| Country Average | 1.1 | ¥2 418.26 |
-45%
|
Forward EV/S
Today’s price vs future revenue
| Today's Enterprise Value | Revenue | Forward EV/S | ||
|---|---|---|---|---|
|
¥138B
|
/ |
Jan 2026
¥63.4B
|
= |
|
|
¥138B
|
/ |
Sep 2026
¥65.1B
|
= |
|
|
¥138B
|
/ |
Sep 2027
¥66.5B
|
= |
|
|
¥138B
|
/ |
Sep 2028
¥67.8B
|
= |
|
Forward EV/S shows whether today’s EV/S still looks high or low once future revenue are taken into account.
Peer Comparison
| Market Cap | EV/S | P/E | ||||
|---|---|---|---|---|---|---|
| JP |
|
Noevir Holdings Co Ltd
TSE:4928
|
150.8B JPY | 2 | 18 | |
| FR |
|
L'Oreal SA
PAR:OR
|
199.5B EUR | 4.5 | 32.8 | |
| UK |
|
Unilever PLC
LSE:ULVR
|
92.2B GBP | 2.6 | 11.3 | |
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.5T INR | 8.2 | 37.1 | |
| UK |
|
HALEON PLC
LSE:HLN
|
31.2B GBP | 3.4 | 18.7 | |
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
28B USD | 2.2 | -157.1 | |
| DE |
|
Beiersdorf AG
XETRA:BEI
|
15.8B EUR | 1.4 | 16.8 | |
| JP |
|
Kao Corp
TSE:4452
|
2.7T JPY | 1.5 | 22.6 | |
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.1T INR | 7.5 | 61.7 | |
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD | 855.7 | -4 624.4 | |
| IN |
|
Dabur India Ltd
NSE:DABUR
|
801.7B INR | 5.8 | 43.3 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0.7 |
| Median | 1.1 |
| 70th Percentile | 2 |
| Max | 12 107 466 |
Other Multiples
Noevir Holdings Co Ltd
Glance View
In the versatile world of beauty and wellness, Noevir Holdings Co Ltd. stands as a testament to astute innovation combined with a well-honed business acumen. Founded in Japan, this company has expertly navigated the delicate balance of tradition and modernity to emerge as a prominent figure in the skincare and cosmetic industries. Noevir's strategy is rooted in the meticulous formulation of its products, drawing inspiration from natural ingredients, which reflects the company’s keen attention to quality and detail. By leveraging advanced research and development techniques, Noevir crafts a diverse range of skincare and personal care products designed to cater to the discerning needs of its clientele. They operate primarily through direct sales channels, allowing them to maintain a personal relationship with their customers, understanding their preferences deeply and ensuring a consistent brand experience. Financially, Noevir Holdings generates revenue by employing a multi-faceted business model, anchoring itself in both domestic and international markets. Besides its leading role in the cosmetics sector, the company diversifies through its involvement in pharmaceuticals and health foods, broadening its portfolio to mitigate market risks. This diversity not only stabilizes the company’s revenue streams but also aligns with the increasing consumer emphasis on holistic health and wellness solutions. Noevir's ability to anticipate and respond to market trends ensures its growth trajectory, having firmly established its brand in the Asian market while progressively expanding its footprint across regions. As a result, the company's strategy encompasses not just product innovation but also a robust marketing and distribution network that reinforces its position as a leader in the beauty and wellness industry.